EyePoint Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Name: EyePoint Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: EyePoint Pharmaceuticals Inc
Rating: 1.67658325
Author: Trendlyne DVM scores

about

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its...

11.35 0.14 (1.25%)

190.28% Gain from 52W Low

999.6K

XNAS Volume

XNAS 10 Nov, 2025 4:30 PM (EST)

Board Meeting

The next board meeting for EyePoint Pharmaceuticals Inc is on 17 Nov 2025 for the purpose of Jefferies London Healthcare ConferenceForum See details

Not Eligible

Expensive Valuation

11.8 / 100

Technically Neutral

55.2 / 100

1Yr Price target upside is 205%

12 analysts

EyePoint Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

EyePoint Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its...

190.28% Gain from 52W Low

SWOT Analysis

EyePoint Pharmaceuticals Inc Live Price Chart